lithium;4-[2-[3-[2-[4-[[1-(2-ethoxyethyl)benzimidazol-2-yl]amino]piperidin-1-yl]ethyl]-3-phenylpyrrolidine-1-carbonyl]-4-(tetrazol-1-yl)phenoxy]butanoic acid;hydride

C40H50LiN9O5 — CID 173233550

IUPAClithium;4-[2-[3-[2-[4-[[1-(2-ethoxyethyl)benzimidazol-2-yl]amino]piperidin-1-yl]ethyl]-3-phenylpyrrolidine-1-carbonyl]-4-(tetrazol-1-yl)phenoxy]butanoic acid;hydride
SMILESCCOCCn1c(NC2CCN(CCC3(c4ccccc4)CCN(C(=O)c4cc(-n5cnnn5)ccc4OCCCC(=O)O)C3)CC2)nc2ccccc21.[H-].[Li+]
InChIInChI=1S/C40H49N9O5.Li.H/c1-2-53-26-24-48-35-12-7-6-11-34(35)43-39(48)42-31-16-20-46(21-17-31)22-18-40(30-9-4-3-5-10-30)19-23-47(28-40)38(52)33-27-32(49-29-41-44-45-49)14-15-36(33)54-25-8-13-37(50)51;;/h3-7,9-12,14-15,27,29,31H,2,8,13,16-26,28H2,1H3,(H,42,43)(H,50,51);;/q;+1;-1
InChIKeyZOZQVEKYMHHBAM-UHFFFAOYSA-N
MW743.84 g/mol
LogP2.16
Rot. Bonds17

About lithium;4-[2-[3-[2-[4-[[1-(2-ethoxyethyl)benzimidazol-2-yl]amino]piperidin-1-yl]ethyl]-3-phenylpyrrolidine-1-carbonyl]-4-(tetrazol-1-yl)phenoxy]butanoic acid;hydride

lithium;4-[2-[3-[2-[4-[[1-(2-ethoxyethyl)benzimidazol-2-yl]amino]piperidin-1-yl]ethyl]-3-phenylpyrrolidine-1-carbonyl]-4-(tetrazol-1-yl)phenoxy]butanoic acid;hydride (PubChem CID 173233550) has the molecular formula C40H50LiN9O5 and a molecular weight of 743.84 g/mol. Its IUPAC name is lithium;4-[2-[3-[2-[4-[[1-(2-ethoxyethyl)benzimidazol-2-yl]amino]piperidin-1-yl]ethyl]-3-phenylpyrrolidine-1-carbonyl]-4-(tetrazol-1-yl)phenoxy]butanoic acid;hydride.

Molecular Properties

Compound Namelithium;4-[2-[3-[2-[4-[[1-(2-ethoxyethyl)benzimidazol-2-yl]amino]piperidin-1-yl]ethyl]-3-phenylpyrrolidine-1-carbonyl]-4-(tetrazol-1-yl)phenoxy]butanoic acid;hydride
PubChem CID173233550
Molecular FormulaC40H50LiN9O5
Molecular Weight743.84 g/mol
Exact Mass743.41
IUPAC Namelithium;4-[2-[3-[2-[4-[[1-(2-ethoxyethyl)benzimidazol-2-yl]amino]piperidin-1-yl]ethyl]-3-phenylpyrrolidine-1-carbonyl]-4-(tetrazol-1-yl)phenoxy]butanoic acid;hydride
SMILESCCOCCn1c(NC2CCN(CCC3(c4ccccc4)CCN(C(=O)c4cc(-n5cnnn5)ccc4OCCCC(=O)O)C3)CC2)nc2ccccc21.[H-].[Li+]
InChIInChI=1S/C40H49N9O5.Li.H/c1-2-53-26-24-48-35-12-7-6-11-34(35)43-39(48)42-31-16-20-46(21-17-31)22-18-40(30-9-4-3-5-10-30)19-23-47(28-40)38(52)33-27-32(49-29-41-44-45-49)14-15-36(33)54-25-8-13-37(50)51;;/h3-7,9-12,14-15,27,29,31H,2,8,13,16-26,28H2,1H3,(H,42,43)(H,50,51);;/q;+1;-1
InChIKeyZOZQVEKYMHHBAM-UHFFFAOYSA-N
XLogP2.16
TPSA152.76 Ų
H-Bond Donors2
H-Bond Acceptors12
Rotatable Bonds17
Heavy Atoms55
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500743.84
LogP ≤ 52.16
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1012

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze lithium;4-[2-[3-[2-[4-[[1-(2-ethoxyethyl)benzimidazol-2-yl]amino]piperidin-1-yl]ethyl]-3-phenylpyrrolidine-1-carbonyl]-4-(tetrazol-1-yl)phenoxy]butanoic acid;hydride with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of lithium;4-[2-[3-[2-[4-[[1-(2-ethoxyethyl)benzimidazol-2-yl]amino]piperidin-1-yl]ethyl]-3-phenylpyrrolidine-1-carbonyl]-4-(tetrazol-1-yl)phenoxy]butanoic acid;hydride?
The IUPAC name of lithium;4-[2-[3-[2-[4-[[1-(2-ethoxyethyl)benzimidazol-2-yl]amino]piperidin-1-yl]ethyl]-3-phenylpyrrolidine-1-carbonyl]-4-(tetrazol-1-yl)phenoxy]butanoic acid;hydride (CID 173233550) is lithium;4-[2-[3-[2-[4-[[1-(2-ethoxyethyl)benzimidazol-2-yl]amino]piperidin-1-yl]ethyl]-3-phenylpyrrolidine-1-carbonyl]-4-(tetrazol-1-yl)phenoxy]butanoic acid;hydride.
What is the SMILES notation for lithium;4-[2-[3-[2-[4-[[1-(2-ethoxyethyl)benzimidazol-2-yl]amino]piperidin-1-yl]ethyl]-3-phenylpyrrolidine-1-carbonyl]-4-(tetrazol-1-yl)phenoxy]butanoic acid;hydride?
The canonical SMILES for lithium;4-[2-[3-[2-[4-[[1-(2-ethoxyethyl)benzimidazol-2-yl]amino]piperidin-1-yl]ethyl]-3-phenylpyrrolidine-1-carbonyl]-4-(tetrazol-1-yl)phenoxy]butanoic acid;hydride is CCOCCn1c(NC2CCN(CCC3(c4ccccc4)CCN(C(=O)c4cc(-n5cnnn5)ccc4OCCCC(=O)O)C3)CC2)nc2ccccc21.[H-].[Li+].
What is the InChIKey of lithium;4-[2-[3-[2-[4-[[1-(2-ethoxyethyl)benzimidazol-2-yl]amino]piperidin-1-yl]ethyl]-3-phenylpyrrolidine-1-carbonyl]-4-(tetrazol-1-yl)phenoxy]butanoic acid;hydride?
The InChIKey is ZOZQVEKYMHHBAM-UHFFFAOYSA-N. The full InChI is InChI=1S/C40H49N9O5.Li.H/c1-2-53-26-24-48-35-12-7-6-11-34(35)43-39(48)42-31-16-20-46(21-17-31)22-18-40(30-9-4-3-5-10-30)19-23-47(28-40)38(52)33-27-32(49-29-41-44-45-49)14-15-36(33)54-25-8-13-37(50)51;;/h3-7,9-12,14-15,27,29,31H,2,8,13,16-26,28H2,1H3,(H,42,43)(H,50,51);;/q;+1;-1.
What are the key properties of lithium;4-[2-[3-[2-[4-[[1-(2-ethoxyethyl)benzimidazol-2-yl]amino]piperidin-1-yl]ethyl]-3-phenylpyrrolidine-1-carbonyl]-4-(tetrazol-1-yl)phenoxy]butanoic acid;hydride?
lithium;4-[2-[3-[2-[4-[[1-(2-ethoxyethyl)benzimidazol-2-yl]amino]piperidin-1-yl]ethyl]-3-phenylpyrrolidine-1-carbonyl]-4-(tetrazol-1-yl)phenoxy]butanoic acid;hydride has a molecular weight of 743.84 g/mol, XLogP of 2.16, 17 rotatable bonds, 2 hydrogen bond donors, and 12 hydrogen bond acceptors.
Where does this data come from?
All data for lithium;4-[2-[3-[2-[4-[[1-(2-ethoxyethyl)benzimidazol-2-yl]amino]piperidin-1-yl]ethyl]-3-phenylpyrrolidine-1-carbonyl]-4-(tetrazol-1-yl)phenoxy]butanoic acid;hydride is sourced from PubChem (CID 173233550), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).